Melatonin prevents glucocorticoid inhibition of cell proliferation and toxicity in hippocampal cells by reducing glucocorticoid receptor nuclear translocation

Journal of Steroid Biochemistry and Molecular Biology

Volumn 110, Issue 1-2, 2008, Pages 116-124

  Quiros, Isabel ^a   Mayo, Juan C ^a   Garcia Suarez, Olivia ^a   Hevia, David ^a   Martin, Vanesa ^a   Rodríguez, Carmen ^a   Sainz, Rosa M ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

Cell proliferation; Glucocorticoids; Hippocampal cells; HT22; Melatonin

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; MELATONIN; NEUROTOXIN;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL DAMAGE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOLYSIS; DRUG INHIBITION; HIPPOCAMPUS; HUMAN; HUMAN CELL; NERVE CELL; NONHUMAN; RAT;

ANIMALS; BLOTTING, WESTERN; CELL CYCLE; CELL DEATH; CELL LINE; CELL NUCLEUS; CELL PROLIFERATION; DEXAMETHASONE; GLUCOCORTICOIDS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MELATONIN; MICE; NEUROTOXINS; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, GLUCOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

RATTUS;

EID: 44649120768     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.02.009     Document Type: Article

References (49)

1. Ashwell J.D., Lu F.W., and Vacchio M.S. Glucocorticoids in T cell development and function. Annu. Rev. Immunol. 18 (2000) 309-345
2. Harmon J.M., Norman M.R., Fowlkes B.J., and Thompson E.B. Dexamethasone induces irreversible G1 arrest and death of a human lymphoid cell line. J. Cell Physiol. 98 2 (1979) 267-278
3. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284 5756 (1980) 555-556
4. McKay L.I., and Cidlowski J.A. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr. Rev. 20 4 (1999) 435-459
5. McEwen B.S. Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. Metabolism 54 5 Suppl. (1) (2005) 20-23
6. Mirescu C., and Gould E. Stress and adult neurogenesis. Hippocampus 16 3 (2006) 233-238
7. Cameron H.A., and Gould E. Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus. Neuroscience 61 2 (1994) 203-209
8. Mirescu C., Peters J.D., and Gould E. Early life experience alters response of adult neurogenesis to stress. Nat. Neurosci. 7 8 (2004) 841-846
9. Jiang W., Zhu Z., Bhatia N., Agarwal R., and Thompson H.J. Mechanisms of energy restriction: effects of corticosterone on cell growth, cell cycle machinery, and apoptosis. Cancer Res. 62 18 (2002) 5280-5287
10. Kim J.B., Ju J.Y., Kim J.H., Kim T.Y., Yang B.H., Lee Y.S., and Son H. Dexamethasone inhibits proliferation of adult hippocampal neurogenesis in vivo and in vitro. Brain Res. 1027 1-2 (2004) 1-10
11. Yusim A., Ajilore O., Bliss T., and Sapolsky R. Glucocorticoids exacerbate insult-induced declines in metabolism in selectively vulnerable hippocampal cell fields. Brain Res. 870 1-2 (2000) 109-117
12. Behl C., Lezoualc'h F., Trapp T., Widmann M., Skutella T., and Holsboer F. Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro. Endocrinology 138 1 (1997) 101-106
13. Almeida O.F., Conde G.L., Crochemore C., Demeneix B.A., Fischer D., Hassan A.H., Meyer M., Holsboer F., and Michaelidis T.M. Subtle shifts in the ratio between pro- and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate. FASEB J. 14 5 (2000) 779-790
14. McEwen B.S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 87 3 (2007) 873-904
15. Crochemore C., Michaelidis T.M., Fischer D., Loeffler J.P., and Almeida O.F. Enhancement of p53 activity and inhibition of neural cell proliferation by glucocorticoid receptor activation. FASEB J. 16 8 (2002) 761-770
16. McEwen B.S., and Sapolsky R.M. Stress and cognitive function. Curr. Opin. Neurobiol. 5 2 (1995) 205-216
17. Reiter R.J. The pineal and its hormones in the control of reproduction in mammals. Endocr. Rev. 1 2 (1980) 109-131
18. Blask D.E., Sauer L.A., and Dauchy R.T. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr. Top. Med. Chem. 2 2 (2002) 113-132
19. Conti A., Conconi S., Hertens E., Skwarlo-Sonta K., Markowska M., and Maestroni J.M. Evidence for melatonin synthesis in mouse and human bone marrow cells. J. Pineal Res. 28 4 (2000) 193-202
20. Tan D.X., Manchester L.C., Terron M.P., Flores L.J., and Reiter R.J. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?. J. Pineal Res. 42 1 (2007) 28-42
21. Tan D.X., Manchester L.C., Reiter R.J., Qi W., Kim S.J., and El-Sokkary G.H. Ischemia/reperfusion-induced arrhythmias in the isolated rat heart: prevention by melatonin. J. Pineal Res. 25 3 (1998) 184-191
22. Pappolla M.A., Simovich M.J., Bryant-Thomas T., Chyan Y.J., Poeggeler B., Dubocovich M., Bick R., Perry G., Cruz-Sanchez F., and Smith M.A. The neuroprotective activities of melatonin against the Alzheimer beta-protein are not mediated by melatonin membrane receptors. J. Pineal Res. 32 3 (2002) 135-142
23. Mayo J.C., Sainz R.M., Tan D.X., Antolin I., Rodriguez C., and Reiter R.J. Melatonin and Parkinson's disease. Endocrine 27 2 (2005) 169-178
24. Vaughan M.K., and Reiter R.J. Transient hypertrophy of the ventral prostate and coagulating glands and accelerated thymic involution following pinealectomy in the mouse. Tex. Rep. Biol. Med. 29 4 (1971) 579-586
25. Maestroni G.J. MLT and the immune-hematopoietic system. Adv. Exp. Med. Biol. 460 (1999) 395-405
26. Sainz R.M., Mayo J.C., Reiter R.J., Antolin I., Esteban M.M., and Rodriguez C. Melatonin regulates glucocorticoid receptor: an answer to its antiapoptotic action in thymus. FASEB J. 13 12 (1999) 1547-1556
27. Presman D.M., Hoijman E., Ceballos N.R., Galigniana M.D., and Pecci A. Melatonin inhibits glucocorticoid receptor nuclear translocation in mouse thymocytes. Endocrinology 147 11 (2006) 5452-5459
28. Gomez M., Esparza J.L., Nogues M.R., Giralt M., Cabre M., and Domingo J.L. Pro-oxidant activity of aluminum in the rat hippocampus: gene expression of antioxidant enzymes after melatonin administration. Free Radic. Biol. Med. 38 1 (2005) 104-111
29. Kim M.J., Kim H.K., Kim B.S., and Yim S.V. Melatonin increases cell proliferation in the dentate gyrus of maternally separated rats. J. Pineal Res. 37 3 (2004) 193-197
30. Kiefer T.L., Lai L., Yuan L., Dong C., Burow M.E., and Hill S.M. Differential regulation of estrogen receptor alpha, glucocorticoid receptor and retinoic acid receptor alpha transcriptional activity by melatonin is mediated via different G proteins. J. Pineal Res. 38 4 (2005) 231-239
31. Persengiev S.P. The neuroprotective and antiapoptotic effects of melatonin in cerebellar neurons involve glucocorticoid receptor and p130 signal pathways. J. Steroid Biochem. Mol. Biol. 77 2-3 (2001) 151-158
32. McEwen B.S., Macewen B.S., and Weiss J.M. The uptake and action of corticosterone: regional and subcellular studies on rat brain. Prog. Brain Res. 32 (1970) 200-212
33. Uno H., Tarara R., Else J.G., Suleman M.A., and Sapolsky R.M. Hippocampal damage associated with prolonged and fatal stress in primates. J. Neurosci. 9 5 (1989) 1705-1711
34. Yu I.T., Lee S.H., Lee Y.S., and Son H. Differential effects of corticosterone and dexamethasone on hippocampal neurogenesis in vitro. Biochem. Biophys. Res. Commun. 317 2 (2004) 484-490
35. Mayo J.C., Sainz R.M., Uria H., Antolin I., Esteban M.M., and Rodriguez C. Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells: implications for Parkinson's disease. J. Pineal Res. 24 3 (1998) 179-192
36. Lezoualc'h F., Skutella T., Widmann M., and Behl C. Melatonin prevents oxidative stress-induced cell death in hippocampal cells. Neuroreport 7 13 (1996) 2071-2077
37. Pappolla M.A., Sos M., Omar R.A., Bick R.J., Hickson-Bick D.L., Reiter R.J., Efthimiopoulos S., and Robakis N.K. Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J. Neurosci. 17 5 (1997) 1683-1690
38. Matsubara E., Bryant-Thomas T., Pacheco Q.J., Henry T.L., Poeggeler B., Herbert D., Cruz-Sanchez F., Chyan Y.J., Smith M.A., Perry G., Shoji M., Abe K., Leone A., Grundke-Ikbal I., Wilson G.L., Ghiso J., Williams C., Refolo L.M., Pappolla M.A., Chain D.G., and Neria E. Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease. J. Neurochem. 85 5 (2003) 1101-1108
39. Reiter R.J., Cabrera J., Sainz R.M., Mayo J.C., Manchester L.C., and Tan D.X. Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington's disease, Alzheimer's disease and parkinsonism. Ann. N. Y. Acad. Sci. 890 (1999) 471-485
40. Gorfine T., and Zisapel N. Melatonin and the human hippocampus, a time dependant interplay. J. Pineal Res. 43 1 (2007) 80-86
41. Savaskan E., Ayoub M.A., Ravid R., Angeloni D., Fraschini F., Meier F., Eckert A., Muller-Spahn F., and Jockers R. Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease. J. Pineal Res. 38 1 (2005) 10-16
42. Wu Y.H., and Swaab D.F. The human pineal gland and melatonin in aging and Alzheimer's disease. J. Pineal Res. 38 3 (2005) 145-152
43. Ladizesky M.G., Boggio V., Cutrera R.A., Mondelo N., Mastaglia S., Somoza J., and Cardinali D.P. Melatonin effect on bone metabolism in rats treated with methylprednisolone. J. Pineal Res. 40 4 (2006) 297-304
44. Sainz R.M., Mayo J.C., Uria H., Kotler M., Antolin I., Rodriguez C., and Menendez-Pelaez A. The pineal neurohormone melatonin prevents in vivo and in vitro apoptosis in thymocytes. J. Pineal Res. 19 4 (1995) 178-188
45. Herrera F., Martin V., Garcia-Santos G., Rodriguez-Blanco J., Antolin I., and Rodriguez C. Melatonin prevents glutamate-induced oxytosis in the HT22 mouse hippocampal cell line through an antioxidant effect specifically targeting mitochondria. J. Neurochem. 100 3 (2007) 736-746
46. Post A., Holsboer F., and Behl C. Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-kappaB and neuroprotection by antioxidants. J. Neurosci. 18 20 (1998) 8236-8246
47. Mayo J.C., Sainz R.M., Antolin I., Herrera F., Martin V., and Rodriguez C. Melatonin regulation of antioxidant enzyme gene expression. Cell Mol. Life Sci. 59 10 (2002) 1706-1713
48. Madrigal J.L., Garcia-Bueno B., Caso J.R., Perez-Nievas B.G., and Leza J.C. Stress-induced oxidative changes in brain. CNS Neurol. Disord. Drug Targets 5 5 (2006) 561-568
49. Wang X., Pongrac J.L., and DeFranco D.B. Glucocorticoid receptors in hippocampal neurons that do not engage proteasomes escape from hormone-dependent down-regulation but maintain transactivation activity. Mol. Endocrinol. 16 9 (2002) 1987-1998